GUIDED THERAPEUTICS INC
Loading stock data...
Key Financial Metrics (TTM | FY 2024)
$178.00K
Revenue
$-2.21M
Net Income
-0.05
EPS (Diluted)
$-1.94M
Free Cash Flow
Profitability
Gross Margin
62.92%
Operating Margin
-1233.71%
Net Profit Margin
-1239.00%
EBITDA
$-2.20M
Returns & Efficiency
Return on Assets (ROA)
-244.23%
Return on Equity (ROE)
-
Gross Profit
$112.00K
Operating Income
$-2.20M
Financial Health
Total Assets
$903.00K
Total Debt
-
Debt to Equity
-x
Current Ratio
0.12
Debt Analysis
Debt to EBITDA
-
Debt to Free Cash Flow
-
Cash & Equivalents
-
Net Debt
-
Capital Returns
Return on Invested Capital (ROIC)
-
Invested Capital
-
Stockholders Equity
-
Revenue Growth
-
Market Valuation
Market Cap
-
P/E Ratio
-
Price to Book
-
EPS (Diluted)
$-0.05
Quick Access Filings
10-K
Annual Report
Loading...
10-Q
Quarterly Report
Loading...
8-K
Recent News
Loading...
Company Data Library
Earnings Transcripts
Loading...
Press Releases
Loading...
Filing Sections
Loading...
Financial Charts Annual (10-K)
Interactive financial visualizations
Show:
Revenue & Income Trends
Revenue & Profit
Profit Margins
Balance Sheet Breakdown
Assets Composition
Capital Structure
Cash Flow Analysis
Cash Flow Components
Free Cash Flow
Growth & Performance
Revenue Growth Rate (YoY %)
Key Ratio Trends
Insider Transactions
Neutral
Open Market Buys: -
Open Market Sales: -
Option Exercise & Sale: -
Net: -
Loading...
Loading insider transactions...
My Notes & Files
Personal Notes
Attached Files
Loading...
SEC Filings by Category
Insider Trading Activity
Neutral
0 Buys $0
0 Sales $0
0 Exercises $0
Net: $0
| Insider | Title | Date | Type | Shares | Price | Value |
|---|
Company Information
| Business Address |
5835 PEACHTREE CORNERS EAST
SUITE B PEACHTREE CORNERS, GA 30092 |
| Phone | 7702428723 |
| Incorporated | DE, US |
| EIN | 582029543 |
| Fiscal Year End | 1231 |
| Stockholders' Equity | $-5.65M |
Recent Filings
View All
8-K
Current Report
Report of material events (acquisitions, earnings, executive changes)
Filed: 2026-03-10
Local
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-03-04
Local
10-Q
Quarterly Report
Quarterly financial report with unaudited statements
Filed: 2025-11-13
Local
10-Q
Quarterly Report
Quarterly financial report with unaudited statements
Filed: 2025-08-14
Local
10-Q
Quarterly Report
Quarterly financial report with unaudited statements
Filed: 2025-05-15
Local
10-K
Annual Report
Comprehensive annual financial report with audited statements
Filed: 2025-03-31
Local
10-Q
Quarterly Report
Quarterly financial report with unaudited statements
Filed: 2024-11-14
Local
10-Q
Quarterly Report
Quarterly financial report with unaudited statements
Filed: 2024-08-14
Local
10-Q
Quarterly Report
Quarterly financial report with unaudited statements
Filed: 2024-05-14
Local
10-K
Annual Report
Comprehensive annual financial report with audited statements
Filed: 2024-03-28
Local
10-Q
Quarterly Report
Quarterly financial report with unaudited statements
Filed: 2023-11-13
Local
10-Q
Quarterly Report
Quarterly financial report with unaudited statements
Filed: 2023-08-10
Local
10-Q
Quarterly Report
Quarterly financial report with unaudited statements
Filed: 2023-05-15
Local
10-K
Annual Report
Comprehensive annual financial report with audited statements
Filed: 2023-03-30
Local
10-Q
Quarterly Report
Quarterly financial report with unaudited statements
Filed: 2022-11-14
Local
Financial Statistics
Valuation
Market Cap
-
P/E Ratio (TTM)
-
Price to Book
-
EV/Revenue
-
EV/EBITDA
-
Profitability
Gross Margin
62.9%
Operating Margin
-1233.7%
Net Margin
-1239.0%
ROE
-
ROA
-244.2%
Leverage & Liquidity
Debt to Equity
-
Current Ratio
0.12
Total Debt
-
Total Assets
$903.00K
Stockholders' Equity
$-5.65M
Income Statement (FY 2024)
Revenue
$178.00K
Gross Profit
$112.00K
Operating Income
$-2.20M
Net Income
$-2.21M
EPS (Diluted)
$-0.05
Cash Flow (FY 2024)
Free Cash Flow
$-1.94M
Cash & Equivalents
-
Revenue Growth
2442.9%
Loading...
Loading management data...
Loading...
Loading board of directors...
Loading...
Loading institutional holders...